Loading...
XJPX2914
Market cap47bUSD
Dec 20, Last price  
4,143.00JPY
1D
-0.36%
1Q
1.20%
Jan 2017
7.78%
Name

Japan Tobacco Inc

Chart & Performance

D1W1MN
XJPX:2914 chart
P/E
15.25
P/S
2.59
EPS
271.62
Div Yield, %
4.99%
Shrs. gr., 5y
-0.19%
Rev. gr., 5y
5.10%
Revenues
2.84t
+6.89%
4,664,514,000,0004,637,657,000,0004,769,387,000,0006,409,727,000,0006,832,307,000,0006,134,695,000,0006,194,554,000,0002,033,825,000,0002,120,196,000,0002,399,841,000,0002,019,745,000,0002,252,884,000,0002,143,287,000,0002,139,653,000,0002,215,962,000,0002,175,626,000,0002,092,561,000,0002,324,838,000,0002,657,832,000,0002,841,077,000,000
Net income
482.29b
+8.94%
62,584,000,000201,542,000,000210,772,000,000238,702,000,000123,400,000,000138,448,000,000144,962,000,000320,883,000,000343,612,000,000427,987,000,000362,919,000,000485,691,000,000421,695,000,000392,409,000,000385,676,000,000348,190,000,000310,254,000,000338,490,000,000442,716,000,000482,289,000,000
CFO
567.01b
+17.20%
250,840,000,000150,343,000,000435,958,000,000145,030,000,000275,271,000,000320,024,000,000399,638,000,000551,573,000,000466,608,000,000396,496,000,000543,696,000,000468,432,000,000376,549,000,000419,212,000,000461,389,000,000540,410,000,000519,833,000,000598,909,000,000483,799,000,000567,014,000,000
Dividend
Dec 27, 202497 JPY/sh
Earnings
Mar 21, 2025

Profile

Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, prescription drugs, and processed foods in Japan and internationally. The company operates through four segments: Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. It offers tobacco products, such as cigarettes, cigars, pipe tobacco, oral tobacco, waterpipe tobacco, kretek, and fine cut products under the Winston, Camel, MEVIUS, and LD brands. The company also provides reduced-risk products, including tobacco-infused vapor and heated tobacco products, E-Vapor products, etc. under the Ploom, Logic, Ploom TECH, Ploom TECH+, and Ploom S brands. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, renal and metabolism, immunology, and neuroscience. Further, the company provides staple food products, such as frozen noodles and okonomiyaki, and frozen and packed cooked rice; ambient processed foods; bakery products; and seasonings, including yeast extracts and oyster sauce. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.
URL
https://www.jti.co.jp/
IPO date
Oct 27, 1994
Employees
52,640
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
2,841,077,000
6.89%
2,657,832,000
14.32%
2,324,838,000
11.10%
Cost of revenue
2,080,461,000
2,336,708,000
2,115,288,000
Unusual Expense (Income)
NOPBT
760,616,000
321,124,000
209,550,000
NOPBT Margin
26.77%
12.08%
9.01%
Operating Taxes
136,292,000
149,277,000
132,208,000
Tax Rate
17.92%
46.49%
63.09%
NOPAT
624,324,000
171,847,000
77,342,000
Net income
482,289,000
8.94%
442,716,000
30.79%
338,490,000
9.10%
Dividends
(367,331,000)
(266,175,000)
(251,935,000)
Dividend yield
5.68%
5.63%
6.11%
Proceeds from repurchase of equity
(1,000)
(1,000)
59,108,000
BB yield
0.00%
0.00%
-1.43%
Debt
Debt current
233,333,000
137,308,000
142,901,000
Long-term debt
946,715,000
861,010,000
817,811,000
Deferred revenue
362,928,000
Other long-term liabilities
492,817,000
507,589,000
179,194,000
Net debt
(82,538,000)
(65,876,000)
88,602,000
Cash flow
Cash from operating activities
567,014,000
483,799,000
598,909,000
CAPEX
(94,861,000)
(99,408,000)
(102,918,000)
Cash from investing activities
(126,129,000)
(101,822,000)
(97,499,000)
Cash from financing activities
(270,500,000)
(306,176,000)
(353,138,000)
FCF
417,396,000
(17,061,000)
119,833,000
Balance
Cash
1,040,206,000
904,562,000
738,985,000
Long term investments
222,380,000
159,632,000
133,125,000
Excess cash
1,120,532,150
931,302,400
755,868,100
Stockholders' equity
3,665,208,000
3,370,544,000
3,040,666,000
Invested Capital
4,427,035,850
4,113,888,600
3,560,162,900
ROIC
14.62%
4.48%
2.19%
ROCE
13.61%
6.31%
4.78%
EV
Common stock shares outstanding
1,775,557
1,775,383
1,775,161
Price
3,645.00
36.98%
2,661.00
14.57%
2,322.50
10.49%
Market cap
6,471,905,265
36.99%
4,724,294,163
14.59%
4,122,811,422
10.50%
EV
6,471,703,265
4,734,744,163
4,688,322,422
EBITDA
940,268,000
520,775,000
396,607,000
EV/EBITDA
6.88
9.09
11.82
Interest
95,222,000
91,272,000
45,645,000
Interest/NOPBT
12.52%
28.42%
21.78%